Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
1.490
-0.500 (-25.13%)
At close: Apr 4, 2025, 4:00 PM
1.340
-0.150 (-10.07%)
After-hours: Apr 4, 2025, 7:59 PM EDT

Aptevo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
2231239160
Upgrade
Market Cap Growth
-36.76%-36.76%-71.13%-69.36%-75.98%441.56%
Upgrade
Enterprise Value
-1-0-10-06164
Upgrade
Last Close Price
1.494.31294.673776.9612812.3659666.19
Upgrade
PE Ratio
---1.47--
Upgrade
PS Ratio
--3.793.1437.23
Upgrade
PB Ratio
0.460.450.280.6631.699.67
Upgrade
P/TBV Ratio
0.450.450.280.6631.699.67
Upgrade
EV/Sales Ratio
---0.4738.02
Upgrade
Debt / Equity Ratio
1.141.140.440.5513.751.65
Upgrade
Asset Turnover
---0.070.220.08
Upgrade
Quick Ratio
1.401.402.342.891.402.91
Upgrade
Current Ratio
1.721.722.643.151.513.25
Upgrade
Return on Equity (ROE)
-284.28%-284.28%-123.53%73.10%-330.24%-217.49%
Upgrade
Return on Assets (ROA)
-76.06%-76.06%-61.12%-39.42%-24.29%-32.13%
Upgrade
Return on Capital (ROIC)
-110.74%-110.74%-79.25%-78.06%-43.19%-43.48%
Upgrade
Earnings Yield
-1110.40%-1118.99%-510.60%67.97%-73.84%-11.06%
Upgrade
FCF Yield
-1094.53%-1102.99%-344.00%-178.24%-58.10%-18.33%
Upgrade
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q